Press release
What's driving the Adult Malignant Glioma Therapeutics Market Growth? Prominent Players: Merck, F. Hoffmann-La Roche Ltd, Arbor Pharmaceuticals, Pfizer, AbbVie and more
Fortune Business Insights states that the market is likely to reach US$ 2,964.5 Mn at a CAGR of 9.3% in the forecast period.
Browse Complete Report Details at
https://www.fortunebusinessinsights.com/industry-reports/adult-malignant-glioma-therapeutics-market-100572
Some of the leading companies that are operating in the Global Adult Malignant Therapeutics Market are;
• Merck
• F. Hoffmann-La Roche Ltd
• Arbor Pharmaceuticals
• Pfizer
• AbbVie
• Amgen
• Bristol-Myers Squibb
• Sun Pharmaceutical Sdn Bhd
• Teva Pharmaceuticals. and Novocure
According to the World Health Organization (WHO), almost 2,45,000 brain tumor cases are registered every year. Despite advancements in treatment options and awareness regarding prevention of tumor at an early stage, the incidence of brain tumor has been on the rise. With increasing glioma cases and a low survival rate among people diagnosed with glioma, there are several market players focusing solely on the research and development of novel therapeutics to treat adult malignant glioma. The aforementioned factors are driving the global adult malignant glioma therapeutics market.
New Imaging Technique May Help Remove Malignant Tumor Altogether
Researchers have come up with a new imaging technique that may help in eliminating the malignant tumor from the human body, altogether. This imaging method may help surgeons locate the tumor with ease. Researchers have claimed that this technique involves the use of a synthetic version of a molecular compound found in the venom of a scorpion. The method also involves the use of an infra-red (IR) camera along with an imaging reagent tozuleristide (BLZ-100).
Get Sample PDF Brochure at
https://www.fortunebusinessinsights.com/industry-reports/adult-malignant-glioma-therapeutics-market-100572
The primary aim of this method was to determine the boundaries between a healthy tissue and tumor. This helps in retaining the healthy tissue after the surgery and thus increases the efficiency of the overall process. Such discoveries are likely to favour growth of the global adult malignant glioma therapeutics market in the forthcoming years.
Major Table of Content of Adult Malignant Glioma Therapeutics Market are;
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Prevalence of glioma by key countries
4.2 Overview of technological advancements in the glioma therapy
4.3 Recent industry developments such as mergers& acquisitions
4.4 Pipeline Analysis
5. Global Adult Malignant Glioma Therapeutics Market Analysis, Insights and Forecast, 2015-2026
TOC Continued…...!
Blue Earth Announces FDA Clearance for Glioma Drug
In December 2018, Blue Earth announced that it has received FDA clearance for a new drug “Axumin”, which has application in positron emission tomography (PET) imaging for removing tumors. The company announced that Fluciclovin (or Axumin) enables PET imaging that may help detect the precise location of the tumor within the body. Along with precise location, the size and severity of tumor can also be traced. This will massively help in treating the malignant glioma disorder and reduce the overall fatality rate among people diagnosed with this disorder. Thus, the FDA approval will help the company take huge strides towards their aim of developing an efficient malignant glioma treatment method. Blue Earth’s success may have impact on the global adult malignant glioma therapeutics market and will lead to growth of the market in the coming years.
STRONG INDUSTRY FOCUS:
• Extensive product offerings
• Customer research services
• Robust research methodology
• Comprehensive reports
• Latest technological developments
• Value chain analysis
• Potential market opportunities
• Growth dynamics
• Quality assurance
• Post-sales support
• Regular report updates
Get Discount at
https://www.fortunebusinessinsights.com/enquiry/check-discount/adult-malignant-glioma-therapeutics-market-100572
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's driving the Adult Malignant Glioma Therapeutics Market Growth? Prominent Players: Merck, F. Hoffmann-La Roche Ltd, Arbor Pharmaceuticals, Pfizer, AbbVie and more here
News-ID: 1848199 • Views: …
More Releases from Fortune Business Insights
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview
The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to…
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview
The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by…
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview:
The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%.
These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth…
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period.
The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution…
More Releases for Malignant
Malignant Mesothelioma Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Malignant Mesothelioma Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Adult Malignant Glioma Therapeutics Market - Defying the Tumor, Empowering Survi …
Newark, New Castle, USA - new report, titled Adult Malignant Glioma Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Adult Malignant Glioma Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Adult Malignant Glioma Therapeutics market. The report offers…
Malignant Mesothelioma-Pipeline Review H2 2018
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Human Parainfluenza Virus 3 Infections-Pipeline Review, H2 2018, provides an overview of the Human Parainfluenza Virus 3 Infections (Infectious Disease) pipeline landscape.
Human parainfluenza virus 3 is a life-threatening infection that causes respiratory illnesses in infants and young children. Symptoms include fever, cough, runny nose, croup, bronchiolitis, wheezing and sore throat. Treatment includes over-the-counter medications for pain and fever.
Report Highlights
Publisher's Pharmaceutical…
Malignant Mesothelioma-Pipeline Review H2 2018
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Malignant Mesothelioma-Pipeline Review, H2 2018, provides an overview of the Malignant Mesothelioma (Oncology) pipeline landscape.
Malignant pleural mesothelioma is a rare cancer often diagnosed in people who have been exposed to high levels of asbestos. The malignancy affects the pleura, a thin membrane of lubricating cells that lines the lungs and chest wall. Peritoneal mesothelioma originates in the abdomen and as a result,…
Malignant Melanoma Drug Market Malignant Melanoma Clinical Pipeline Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Malignant Melanoma
2. Malignant Melanoma Drug Mechanism of Action
3. Global Malignant Melanoma Market Analysis
3.1 Current Market Scenario
3.2 Global Malignant Melanoma Pipeline Overview
4. Global Malignant Melanoma Drug Market Dynamics
4.1 Favorable Market Parameters
4.2 Commercialization Challenges
5. Global Malignant Melanoma Drug Market Future Prospects
6. Global Malignant Melanoma Clinical Pipeline By…
Rising Number of People Diagnosed with Malignant Glioma Supports the Growth of t …
Glioma is a type of tumor that occurs in brain or spine. It is a group of brain tumor that includes oligodendrogliomas and astrocytomas. Gliomas include all types of brain tumors arising from supportive tissue of the brain. Malignant glioma is the most common type of brain tumor observed in adults globally. Collectively they contribute around 40% of the total cases diagnosed with brain tumor. In the last decade, there…
